Ginger Wildheart says he won’t receive treatment for cancer diagnosis: “I’ve lived the life of ten men and will die with dignity”

Ginger Wildheart, the frontman of rock band The Wildhearts, has issued a heartfelt statement after he was sadly diagnosed with Mantle Cell Lymphoma.

His band, The Wildhearts, announced his condition in a social media post on March 16th, revealing that Ginger had begun experiencing unexplained pain, which he nursed with painkillers during their most recent tour in December 2025.

Their statement continued, “The results have been confirmed and we are saddened to report that Ginger has been diagnosed with Mantle Cell Lymphoma (MCL) – a rare but aggressive strain of cancer.”

Despite his diagnosis, The Wildhearts said their leader was “in fine fettle” and they looked forward to writing new music, adding, “While we process this news and await further medical advice, Ginger wants everyone to know that strength and positivity will prevail and the show WILL go on.”

According to the NHS, Mantle Cell Lymphoma is an uncommon type of non-Hodgkin lymphoma that develops in the lymph nodes before building up in the mantle zone, which can then spread into the blood and lymphatic system.

Now, Wildheart has taken to social media to explain that he won’t seek treatment, and wants to make the most out of every moment he has left.

His message began, “Thank you for all your messages of support I won’t go through treatment. I’ve lived the life of ten men and will die with dignity.”

Looking to the future, he added, “Still got 2-3 years to say goodbye to everyone. And I’ll be rocking until the very last moment.”

On an uplifting note, Ginger concluded, “No misery please. Positivity all the way.”

The Wildhearts are next set to perform at Hangar 34 in Liverpool on April 2nd, and are also set to feature at this year’s Bearded Theory festival in May.

ADD AS A PREFERRED SOURCE ON GOOGLE

Never Miss A Beat

The Far Out Music Newsletter

All the latest music news from the independent voice of culture.
Straight to your inbox.